What is the Retatrutide 32mg Triple Agonist Weight Loss Pen?

The Retatrutide 32mg pre-filled injectable pen is a once-weekly, research-grade weight management aid that activates GLP-1, GIP, and glucagon receptors to support appetite control, fat metabolism, and healthier blood sugar balance.

How does Retatrutide work?

Retatrutide mimics three metabolic hormones: GLP-1 to reduce appetite and regulate glucose, GIP to improve satiety and insulin response, and glucagon receptor activity to promote fat mobilisation for energy. Together, these pathways support sustainable fat loss and improved metabolic health.

What is the suggested dosage schedule?

A typical titration schedule is: Weeks 1–4: 2 mg weekly; Weeks 5–8: 4 mg; Weeks 9–12: 6 mg; Weeks 13–16: 8 mg; and from Week 17 onwards: 12 mg. Users should remain at the lowest effective dose that controls appetite, under the advice of a healthcare professional.

What are the benefits of using Retatrutide?

Key benefits include support for effective and sustainable weight loss, reduced cravings and overeating, assistance with blood sugar regulation, and improved metabolic balance, all delivered in a convenient once-weekly pen format.

Who should not use this product?

Retatrutide is not recommended for individuals who are pregnant, breastfeeding, or those with contraindicated medical conditions. It should only be used under professional supervision.

Is Retatrutide fully approved?

Retatrutide is still under clinical investigation for obesity, type 2 diabetes, and fatty liver disease. It is not yet an approved therapy and should be used only for research or under qualified medical guidance.

How long does delivery take in South Africa?

Orders are dispatched quickly and delivered within 5–6 working days across South Africa, unless otherwise communicated.

Can I return this product?

Due to the medical and temperature-sensitive nature of this item, returns and exchanges are not accepted.

Is this medical advice?

No. This information is for educational purposes only. Retatrutide is investigational and should be used responsibly under professional supervision. It is not intended to diagnose, treat, cure, or prevent any disease.

What is the Retatrutide 32mg Triple Agonist Pen?

A once-weekly pre-filled injectable pen containing high-purity Retatrutide, a triple-agonist formulation designed to support sustainable fat loss, appetite control, and blood sugar balance under professional supervision.

How should I titrate the dose?

Use the built-in selector to escalate gradually: Weeks 1–4: 2 mg; Weeks 5–8: 4 mg; Weeks 9–12: 6 mg; Weeks 13–16: 8 mg; From Week 17: 12 mg, remaining at the lowest effective dose as advised by your healthcare professional.

RETATRUTIDE 32 packaging with a pen on a white background

Retatrutide 32mg Triple Agonist Weight Loss Pen – South Africa

Regular price ~~R 3,899.00~~ R 3,499.00 ZAR 10% OFF

ONLY 130 LEFT

Product Details

Retatrutide 32mg Triple Agonist Weight Loss Pen – South Africa

Retatrutide 32mg Pre-Filled Injectable Pen is an advanced triple-agonist designed to support sustainable fat loss, appetite control, and healthier blood sugar balance. Each pen contains high-purity Retatrutide in a convenient, once-weekly format for precise, consistent dosing.

How Retatrutide Works

Retatrutide mimics the actions of three key metabolic hormones:

GLP-1 (glucagon-like peptide-1): helps reduce appetite, slow gastric emptying, and support post-meal glucose control.
GIP (gastric inhibitory polypeptide): plays a role in lowering blood sugar levels after eating and improving satiety.
Glucagon receptor activity (GCG): promotes metabolic efficiency and helps the body mobilise fat for energy.

This multi-pathway approach supports calorie reduction and better metabolic health, helping you stay fuller for longer while progressing toward weight-management goals.

Key Benefits

Supports effective, sustainable weight loss
Helps reduce cravings and overeating
Assists with blood sugar regulation and metabolic balance
Convenient once-weekly pre-filled pen with adjustable dose selector

Suggested Dose-Titration Schedule

Use the built-in selector to increase gradually for tolerance and results:

Week 1–4: 2 mg (2 mg marker)
Week 5–8: 4 mg (4 mg marker)
Week 9–12: 6 mg (6 mg marker)
Week 13–16: 8 mg (8 mg marker)
From Week 17: 12 mg (12 mg marker)

Remain at the lowest dose that keeps appetite under control and weight trending down, as advised by your healthcare professional.

Retatrutide 32 pre-filled injectable pen packaging with BP Body Pharm branding on a pink background.

Important Information & Safety

Retatrutide is being investigated for obesity management, type 2 diabetes, and fatty liver disease and is not yet an approved combined therapy. Use under the guidance of a qualified healthcare provider. Not recommended for those who are pregnant or breastfeeding, or for individuals with contraindicated medical conditions.

Delivery & Returns (South Africa)

Orders dispatch promptly with delivery in 5–6 working days unless otherwise communicated. Due to the temperature-sensitive and hygienic nature of this item, returns and exchanges cannot be accepted.

Why Buy This Pen

The Retatrutide 32mg Triple Agonist Pen offers South Africans a premium, research-grade option for structured weight management—combining precision dosing with a powerful multi-pathway mechanism to support lasting results when paired with a balanced diet and active lifestyle.

Disclaimer: For research and personal use under professional supervision. This product is not intended to diagnose, treat, cure, or prevent any disease.

people are currently looking at this product

Back to Fat Burners South Africa